Oxidative stress and redox-active iron in Alzheimer's disease

被引:158
作者
Honda, K [1 ]
Casadesus, G [1 ]
Petersen, RB [1 ]
Perry, G [1 ]
Smith, MA [1 ]
机构
[1] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
来源
REDOX-ACTIVE METALS IN NEUROLOGICAL DISORDERS | 2004年 / 1012卷
关键词
Alzheimer's disease; amyloid-beta; iron; mitochondria; redox; RNA;
D O I
10.1196/annals.1306.015
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Many lines of evidence indicate that oxidative stress is one of the earliest events in the genesis of Alzheimer's disease (AD). Iron is a transition metal capable of generating hydroxyl radicals, the most potent reactive oxygen species. Consequently, a disruption in the metabolism of iron has been postulated to have a role in the pathogenesis of AD. Indeed, both senile plaques and neurofibrillary tangles, the major pathological landmarks of AD, as well as neurons in the earliest stages of the disease, show elevated iron deposition. However, it is clear that the iron bound to lesion-associated proteins such as amyloid-beta and tau plays only a minor, late role in the disease, with the RNA-associated iron found in the neuronal cytoplasm occurring early and being of paramount importance. In this regard, it is probably not surprising that there is significant oxidation of cytoplasmic RNA among the populations of neurons vulnerable to AD. In this review, we consider the role of iron-induced oxidative stress as a key event in AD pathophysiology.
引用
收藏
页码:179 / 182
页数:4
相关论文
共 50 条
  • [21] Oxidative stress in Alzheimer’s disease
    Zhichun Chen
    Chunjiu Zhong
    Neuroscience Bulletin, 2014, 30 : 271 - 281
  • [22] Oxidative stress in Alzheimer's disease brain: New insights from redox proteomics
    Butterfield, D. Allan
    Perluigi, Marzia
    Sultana, Rukhsana
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 545 (01) : 39 - 50
  • [23] RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer's Disease
    Awasthi, Sanjay
    Hindle, Ashly
    Sawant, Neha A.
    George, Mathew
    Vijayan, Murali
    Kshirsagar, Sudhir
    Morton, Hallie
    Bunquin, Lloyd E.
    Palade, Philip T.
    Lawrence, J. Josh
    Khan, Hafiz
    Bose, Chhanda
    Reddy, P. Hemachandra
    Singh, Sharda P.
    CELLS, 2021, 10 (11)
  • [24] Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron
    Lavados, Manuel
    Guillon, Marta
    Mujica, Maria Cristina
    Rojo, Leonel E.
    Fuentes, Patricio
    Maccioni, Ricardo B.
    JOURNAL OF ALZHEIMERS DISEASE, 2008, 13 (02) : 225 - 232
  • [25] Zinc and its effects on oxidative stress in Alzheimer's disease
    Yuan, Ye
    Niu, Fenglan
    Liu, Ya
    Lu, Na
    NEUROLOGICAL SCIENCES, 2014, 35 (06) : 923 - 928
  • [26] Management of oxidative stress and other pathologies in Alzheimer's disease
    Simunkova, Miriama
    Alwasel, Saleh H.
    Alhazza, Ibrahim M.
    Jomova, Klaudia
    Kollar, Vojtech
    Rusko, Miroslav
    Valko, Marian
    ARCHIVES OF TOXICOLOGY, 2019, 93 (09) : 2491 - 2513
  • [27] Management of oxidative stress and other pathologies in Alzheimer’s disease
    Miriama Simunkova
    Saleh H. Alwasel
    Ibrahim M. Alhazza
    Klaudia Jomova
    Vojtech Kollar
    Miroslav Rusko
    Marian Valko
    Archives of Toxicology, 2019, 93 : 2491 - 2513
  • [28] MITOCHONDRIAL ALTERATIONS, OXIDATIVE STRESS AND NEUROINFLAMMATION IN ALZHEIMER'S DISEASE
    Verri, M.
    Pastoris, O.
    Dossena, M.
    Aquilani, R.
    Guerriero, F.
    Cuzzoni, G.
    Venturini, L.
    Ricevuti, G.
    Bongiorno, A. I.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2012, 25 (02) : 345 - 353
  • [29] Cerebrospinal fluid oxidative stress markers in Alzheimer's disease
    Sakakibara, Ryuji
    Kawai, Takayuki
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2020, 8 (05): : 232 - 240
  • [30] Alzheimer's disease, oxidative stress and gammahydroxybutyrate
    Mamelak, Mortimer
    NEUROBIOLOGY OF AGING, 2007, 28 (09) : 1340 - 1360